Gastric Signet Ring Cell Carcinoma with Metastasis to the Bone and Bone Marrow in a Patient with 12-Year-Disease-Free Interval and Unusually Long Survival Time
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Gastric cancer (GC) is the second most common malignancy in Korea. Most deaths are due to disease recurrence; hence, efforts have been made to identify the recurrence patterns and establish a therapeutic strategy for GC. A 56-year-old man was diagnosed with signet ring cell carcinoma (SRCC) of the stomach 26 years ago, in December 1992. He had local recurrence in November 2006. The patient visited a hospital for back pain in April 2018. Laboratory tests, computed tomography (CT) scans, bone scan, bone and bone marrow biopsies, and bone marrow aspiration were conducted. Bone scan revealed hotspots indicating tracer uptake in the ribs, sternum, pelvic bones, and multiple vertebrae. Chest and abdominal CT scans revealed no lesion except diffuse osteosclerotic lesions of the bony thorax. Finally, bone marrow studies indicated metastatic SRCC. The patient survived for 26 months after treatment with four regimens of palliative chemotherapy. Each regimen was changed due to disease progression. He died due to pneumonia in June 2020. Metastasis to the bone and bone marrow in GC with a disease-free interval of more than 10 years is extremely rare. The patient had an unusually long survival time compared to that reported in previous studies, which have shown a median survival time of less than 3 months. To the best of our knowledge, in Korea, this is the first case of metastasis of gastric SRCC to the bone and bone marrow with a disease-free interval of more than 10 years.
Abstract
Gastric cancer (GC) is the second most common malignancy in Korea. Most deaths are due to disease recurrence; hence, efforts have been made to identify the recurrence patterns and establish a therapeutic strategy for GC. A 56-year-old man was diagnosed with signet ring cell carcinoma (SRCC) of the stomach 26 years ago, in December 1992. He had local recurrence in November 2006. The patient visited a hospital for back pain in April 2018. Laboratory tests, computed tomography (CT) scans, bone scan, bone and bone marrow biopsies, and bone marrow aspiration were conducted. Bone scan revealed hotspots indicating tracer uptake in the ribs, sternum, pelvic bones, and multiple vertebrae. Chest and abdominal CT scans revealed no lesion except diffuse osteosclerotic lesions of the bony thorax. Finally, bone marrow studies indicated metastatic SRCC. The patient survived for 26 months after treatment with four regimens of palliative chemotherapy. Each regimen was changed due to disease progression. He died due to pneumonia in June 2020. Metastasis to the bone and bone marrow in GC with a disease-free interval of more than 10 years is extremely rare. The patient had an unusually long survival time compared to that reported in previous studies, which have shown a median survival time of less than 3 months. To the best of our knowledge, in Korea, this is the first case of metastasis of gastric SRCC to the bone and bone marrow with a disease-free interval of more than 10 years.
참고문헌 (19)
- Torre LA, "Global cancer incidence and mortality rates and trends--an update", Cancer Epidemiol Biomarkers Prev, 25, pp.16~27 (2016)
- 정규원, "Prediction of Cancer Incidence and Mortality in Korea, 2019", Cancer Research and Treatment, 51(2), pp.431~437 (2019), 대한암학회
- 김찬동, "진행성 위암의 근치적 절제술 후 재발에 영향을 주는 인자", Annals of Surgical Treatment and Research, 65(04), pp.5~5 (2003), 대한외과학회
- Lee JH, "Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection", Surgery, 159, pp.1090~1098 (2016)
- Yoo CH, "Recurrence following curative resection for gastric carcinoma", Br J Surg, 87, pp.236~242 (2000)
- American Joint Committee on Cancer, "Manual for staging of cancer" (1992), JB Lippincott
- American Joint Committee on Cancer, "AJCC cancer staging manual" (1997), Lippincott Williams - Raven
- Wu CW, "Incidence and factors associated with recurrence patterns after intended curative surgery for gastric cancer", World J Surg, 27, pp.153~158 (2003)
- 구기환, "수술 후 12년 만에 재발된 위암 1예", 대한소화기학회지, 70(6), pp.296~300 (2017), 대한소화기학회
- "Gastric cancer. Version 2" (2019)[URL]
- Jae Bong Ahn, "Bone Metastasis in Gastric Cancer Patients", Journal of Gastric Cancer, 11(1), pp.38~45 (2011), 대한위암학회
- Fatma Paksoy Turkoz, "Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival", Journal of Gastric Cancer, 14(3), pp.164~172 (2014), 대한위암학회[DOI]
- Silvestris N, "Natural history of malignant bone disease in gastric cancer : final results of a multicenter bone metastasis survey", PLoS One, 8, pp.e74402~ (2013)
- Kim HS, "Clinical outcome of gastric cancer patients with bone marrow metastases", Oncology, 73, pp.192~197 (2007)
- Blanchette P, "Case report of very late gastric cancer recurrence", Curr Oncol, 20, pp.e161~e164 (2013)
- Noda N, "A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval", Jpn J Clin Oncol, 26, pp.472~475 (1996)
- Mizuno I, "Disseminated carcinomatosis of the bone marrow occurring 11 years after subtotal gastrectomy for gastric cancer", Rinsho Ketsueki, 39, pp.670~675 (1998)
- 권지연, "Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases", Cancer Research and Treatment, 43(4), pp.244~249 (2011), 대한암학회
- Ergun Y, "Gastric cancer patients with bone marrow metastasis : a single-center experience and review of the literature", EJMO, 1, pp.160~163 (2017)